Literature DB >> 15605209

Nailfold video-capillaroscopy in systemic sclerosis.

M Cutolo1, C Pizzorni, A Sulli.   

Abstract

The Raynaud's phenomenon (RP) is the most common and significant clinical condition supporting microvascular analysis as soon as possible. Microvascular involvement is a key feature of RP, and several rheumatic diseases are characterized by the presence of the RP. Nailfold capillary microscopy shows an impressive cost/effectiveness ratio: it is simple, noninvasive and inexpensive.Well-recognized videocapillaroscopic patterns (NVC) have been described mainly in scleroderma (SSc) patients complaining of a secondary RP. The peripheral microvascular damage in SSc is characterized by increasing structural alterations of the capillaries (giant capillaries and microhemorrhages) with progressive decrease of their density. The detection of the scleroderma NCV allows early differentiation between primary RP (functional, not disease associated), and secondary RP (disease associated). Other major NVC patterns have been described in the field of rheumatic diseases. Interestingly, correlations are evident between the NCV and the clinical symptoms, severity of the disease and the laboratory findings. Further clinical and epidemiological studies, as well as a standardized and computerized quantitation of the observed damages are required.

Entities:  

Mesh:

Year:  2004        PMID: 15605209     DOI: 10.1007/s00393-004-0673-5

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  35 in total

1.  Predictive value of nailfold capillaroscopy in the diagnosis of connective tissue diseases.

Authors:  D Blockmans; G Beyens; R Verhaeghe
Journal:  Clin Rheumatol       Date:  1996-03       Impact factor: 2.980

2.  Geographic variation in the prevalence of Raynaud's phenomenon: a 5 region comparison.

Authors:  H R Maricq; P H Carpentier; M C Weinrich; J E Keil; Y Palesch; C Biro; M Vionnet-Fuasset; M Jiguet; I Valter
Journal:  J Rheumatol       Date:  1997-05       Impact factor: 4.666

3.  Vascular disease in diabetes: pathophysiological mechanisms and therapy.

Authors:  J A Colwell; P V Halushka; K E Sarji; M F Lopes-Virella; J Sagel
Journal:  Arch Intern Med       Date:  1979-02

Review 4.  Microvasculature in systemic sclerosis.

Authors:  P H Carpentier; H R Maricq
Journal:  Rheum Dis Clin North Am       Date:  1990-02       Impact factor: 2.670

5.  Prevalence of symptoms of Raynaud's phenomenon in general practice.

Authors:  A Silman; S Holligan; P Brennan; P Maddison
Journal:  BMJ       Date:  1990-09-22

6.  Evidence of cerebral hypoperfusion in scleroderma patients.

Authors:  M Cutolo; F Nobili; A Sulli; C Pizzorni; M Briata; F Faelli; P Vitali; G Mariani; F Copello; B Seriolo; C Barone; G Rodriguez
Journal:  Rheumatology (Oxford)       Date:  2000-12       Impact factor: 7.580

7.  Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases.

Authors:  G Spencer-Green
Journal:  Arch Intern Med       Date:  1998-03-23

8.  Mechanisms of endothelial cell damage in systemic sclerosis and Raynaud's phenomenon.

Authors:  A D Blann; K Illingworth; M I Jayson
Journal:  J Rheumatol       Date:  1993-08       Impact factor: 4.666

Review 9.  Raynaud's phenomenon: a proposal for classification.

Authors:  E C LeRoy; T A Medsger
Journal:  Clin Exp Rheumatol       Date:  1992 Sep-Oct       Impact factor: 4.473

10.  Prognostic significance of nailfold capillary microscopy in patients with Raynaud's phenomenon and scleroderma-pattern abnormalities. A six-year follow-up study.

Authors:  P Zufferey; M Depairon; A M Chamot; M Monti
Journal:  Clin Rheumatol       Date:  1992-12       Impact factor: 2.980

View more
  11 in total

1.  [Systemic sclerosis].

Authors:  B A Michel
Journal:  Z Rheumatol       Date:  2004-12       Impact factor: 1.372

2.  [Diagnostic imaging for connective tissue diseases].

Authors:  B Ostendorf; M Cohnen; A Scherer
Journal:  Z Rheumatol       Date:  2006-10       Impact factor: 1.372

3.  Oxidized low-density lipoprotein alters the effect of matrix stiffness on the formation of endothelial networks and capillary lumens.

Authors:  Madhu S Gundavaram; Tzu Pin Shentu; Gregory B Kowalsky; Suncica Volkov; Dean E Schraufnagel; Irena Levitan
Journal:  Pulm Circ       Date:  2013-12-05       Impact factor: 3.017

Review 4.  Assessing microvascular changes in systemic sclerosis diagnosis and management.

Authors:  Maurizio Cutolo; Alberto Sulli; Vanessa Smith
Journal:  Nat Rev Rheumatol       Date:  2010-08-10       Impact factor: 20.543

5.  Nailfold videocapillaroscopy results in patients with rheumatoid arthritis.

Authors:  Sinem Sag; Mustafa Serdar Sag; Ibrahim Tekeoglu; Ayhan Kamanli; Kemal Nas; Yıldıray Aydın
Journal:  Clin Rheumatol       Date:  2017-06-04       Impact factor: 2.980

Review 6.  Vascular disease in scleroderma.

Authors:  Fredrick M Wigley
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

7.  Ocular findings in patients with systemic sclerosis.

Authors:  Beatriz de A F Gomes; Marcony R Santhiago; Priscilla Magalhães; Newton Kara-Junior; Mário N L de Azevedo; Haroldo V Moraes
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

8.  Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide.

Authors:  Annalisa Borghini; Mirko Manetti; Francesca Nacci; Silvia Bellando-Randone; Serena Guiducci; Marco Matucci-Cerinic; Lidia Ibba-Manneschi; Elisabetta Weber
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

Review 9.  Methods for the morphological and functional evaluation of microvascular damage in systemic sclerosis.

Authors:  Barbara Ruaro; Vanessa Smith; Alberto Sulli; Saskia Decuman; Carmen Pizzorni; Maurizio Cutolo
Journal:  Korean J Intern Med       Date:  2014-12-30       Impact factor: 2.884

10.  Clinical associations of serum leptin and leptin/adiponectin ratio in systemic sclerosis.

Authors:  Małgorzata Michalska-Jakubus; Karolina Sawicka; Emilia Potembska; Małgorzata Kowal; Dorota Krasowska
Journal:  Postepy Dermatol Alergol       Date:  2018-05-16       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.